Stockscreener 앱 받기
38.18
0.34%
0.13
시간 외 거래:
38.19
0.010
+0.03%
Tyra Biosciences Inc 주식(TYRA)의 최신 뉴스
Tyra Biosciences (TYRA) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Forecast Cut: Can Tyra Biosciences Inc continue delivering strong returnsIPO Watch & Smart Swing Trading Techniques - baoquankhu1.vn
Hedge Fund Bets: Is Tyra Biosciences Inc a strong candidate for buy and holdQuarterly Portfolio Report & Smart Allocation Stock Tips - baoquankhu1.vn
Wedbush maintains Tyra Biosciences (TYRA) outperform recommendation - MSN
Tyra Biosciences (TYRA) CFO adds 1,376 shares via employee stock plan - Stock Titan
Tyra Biosciences (TYRA) CEO adds 1,463 ESPP shares, holdings reach 1.36M - Stock Titan
Ideas Watch: Is Tyra Biosciences Incs ROE strong enoughMarket Trend Report & Smart Money Movement Tracker - baoquankhu1.vn
Tyra Biosciences, Inc. $TYRA Shares Acquired by HighVista Strategies LLC - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Reaches New 1-Year HighTime to Buy? - MarketBeat
Boothbay Fund Management LLC Makes New $2.61 Million Investment in Tyra Biosciences, Inc. $TYRA - MarketBeat
Analyst Calls: What are the risks of holding Tyra Biosciences Inc2026 Price Momentum & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Tech Rally: How does MASK correlate with Nasdaq2026 Closing Moves & Community Trade Idea Sharing - baoquankhu1.vn
Tyra Biosciences, Inc. $TYRA Shares Purchased by Commodore Capital LP - MarketBeat
Tyra Biosciences stock hits all-time high at 36.69 USD By Investing.com - Investing.com Canada
Tyra Biosciences stock hits all-time high at 36.69 USD - Investing.com Nigeria
ACMG meeting attendance advances FGFR3 inhibition work, Tyra Biosciences outlines - Traders Union
Director sells three 8,000‑share blocks — TYRA (NASDAQ: TYRA) - Stock Titan
Tyra Biosciences (NASDAQ:TYRA) Sets New 12-Month HighHere's What Happened - MarketBeat
Growth Stocks To Consider – March 9th - Defense World
Trading the Move, Not the Narrative: (TYRA) Edition - Stock Traders Daily
Assessing Tyra Biosciences (TYRA) Valuation After Wider Full Year Loss And Earnings Update - Sahm
TD Cowen Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating - 富途牛牛
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Aug Technicals: Is Tyra Biosciences Incs ROE strong enoughQuarterly Earnings Summary & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Update Recap: Is Tyra Biosciences Inc a strong candidate for buy and holdJuly 2025 Macro Moves & Free Community Consensus Stock Picks - baoquankhu1.vn
Assessing Tyra Biosciences (TYRA) Valuation After William Blair Coverage And Dabogratinib Progress - Sahm
Is Tyra Biosciences Inc stock undervalued right nowJuly 2025 Closing Moves & Growth Focused Stock Reports - baoquankhu1.vn
RA Capital discloses 21.2% Tyra Biosciences (TYRA) stake after dilution - Stock Titan
Tyra Biosciences stock reaches all-time high at 35.75 USD By Investing.com - Investing.com Australia
HC Wainwright Issues Optimistic Forecast for TYRA Earnings - Defense World
Tyra Biosciences stock reaches all-time high at 35.75 USD - Investing.com Nigeria
HC Wainwright Boosts Earnings Estimates for Tyra Biosciences - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year HighHere's Why - MarketBeat
Tyra Biosciences announces $126 million stock sale in block transaction By Investing.com - Investing.com India
Growth Stocks To Keep An Eye On – March 3rd - Defense World
Tyra Bioscience Raises $126 Million in Block Share Sale - TipRanks
Tyra Biosciences announces $126 million stock sale in block transaction - Investing.com Australia
According to the latest filing from the U.S. Securities and Exchange Commission (SEC), biotechnology company Tyra Biosciences has reached an agreement to privately issue 4 million common shares to a major investment management firm. - Bitget
Tyra Biosciences agreed to issue 4 million shares at $31.50 per share to a large investment management firmSEC filing - marketscreener.com
Tyra Biosciences Agreed To Issue 4 Million Shares At $31.50 Per Share To A Large Investment Management FirmSEC Filing - TradingView
Tyra Bios to sell 4.0M shares at $31.50 in $126M ATM block transaction - TradingView
Tyra Biosciences (NASDAQ:TYRA) Shares Down 6.4%Here's What Happened - MarketBeat
TYRA: Oral Dabogratinib targets blockbuster potential in UTUC, NMIBC, and achondroplasia with pivotal data ahead - TradingView
TYRA: Oral dabogratinib targets blockbuster opportunities in UTUC, NMIBC, and achondroplasia - TradingView
Did Deeper Losses and Dabogratinib Progress Just Shift Tyra Biosciences' (TYRA) Investment Narrative? - Yahoo Finance
Oppenheimer Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $50 - 富途牛牛
H.C. Wainwright reiterates Tyra Biosciences stock rating at buy By Investing.com - Investing.com Canada
TYRA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Tyra Biosciences Q4 Loss Widens - marketscreener.com
Tyra Biosciences 10-K: Net loss $119.95M, EPS $(2.01) - TradingView
Tyra Biosciences (NASDAQ: TYRA) maps FGFR oncology and achondroplasia pipeline - Stock Titan
Tyra Biosciences (Nasdaq: TYRA) boosts R&D and outlines 2026 trial catalysts - Stock Titan
Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights - PR Newswire
Tyra Biosciences Narrows Dabogratinib Focus, Teases Mid-Year NMIBC and 2H Achondroplasia Data - MarketBeat
TYRATyra Biosciences, Inc. Latest Stock News & Market Updates - Stock Titan
Nasdaq Moves: What are the risks of holding Tyra Biosciences Inc2025 Market WrapUp & Stepwise Trade Execution Plans - baoquankhu1.vn
TYRA SEC FilingsTyra Biosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Tyra Biosciences (TYRA) Valuation Under Review After ASCO Catalysts And Positive Analyst Attention - simplywall.st
1.20%
0.06%
자본화:
|
볼륨(24시간):